David A. Siegel Amgen Inc Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amgen Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,545,600 shares of AMGN stock, worth $488 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
1,545,600
Previous 784,900
96.92%
Holding current value
$488 Million
Previous $253 Million
59.29%
% of portfolio
0.98%
Previous 0.61%
Shares
30 transactions
Others Institutions Holding AMGN
# of Institutions
3,183Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.3 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.6 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.17 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $169B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...